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Introduction
Long-distance transport in mammalian cells is driven by motor 
proteins that use the energy of ATP hydrolysis to carry vesicle, 
organelle, and multiprotein cargoes along microtubule tracks. In 
general, kinesin motors undergo directed motility toward the 
plus ends of microtubules in the cell periphery and thus drive   
anterograde transport, whereas cytoplasmic dynein moves toward 
the minus ends of microtubules in the cell center and thus drives 
retrograde transport. The activity of these motors must be tightly 
regulated in cells to ensure that ATP hydrolysis and microtubule-
based motility are coupled to cargo transport. Regulation also   
involves attachment of each motor to the correct cargo and trans-
port of that cargo to the proper subcellular destination at the rel-
evant time.
A general model has emerged for kinesin motors that in the 
absence of cargo, the motors are kept in an inactive state by auto-
inhibition (Verhey and Hammond, 2009). The mechanism of   
autoinhibition has been best defined for kinesin-1 (formerly 
conventional kinesin or KIF5; for reviews see Adio et al., 2006; 
Verhey and Hammond, 2009). Work from a variety of laborato-
ries has shown that inactive kinesin-1 motors exist in a folded 
conformation, which allows the tail segment to directly contact 
and inhibit the enzymatic activity of the motor domain. A similar 
mechanism has been proposed to regulate kinesin-3 family mem-
bers. Indeed, the mammalian KIF1A and KIF13B/GAKIN mo-
tors are autoinhibited and exist in a folded conformation, although 
direct interactions between motor and nonmotor domains have 
not been demonstrated (Lee et al., 2004; Yamada et al., 2007; 
Hammond et al., 2009).
Two members of the kinesin-2 family have been described: 
the heterotrimeric KIF3A–KIF3B–KAP complex and the homo-
dimeric KIF17 motor. Kinesin-2 motors participate in a variety of 
intracellular transport events, from axonal transport in neurons to 
intraflagellar transport in cilia and flagella (Hirokawa et al., 2009; 
Silverman and Leroux, 2009). An attractive possibility for regu-
lation of kinesin-2 motors is that they are kept inactive in the   
absence of cargo and then activated for transport upon cargo 
binding. Strong support for this possibility was provided by 
Imanishi et al. (2006), who showed that full-length (FL) recombi-
nant Caenorhabditis elegans OSM-3, the homologue of mam-
malian KIF17, shows little to no motility in vitro and undergoes a 
salt-dependent shift from a compact to an extended conforma-
tion. The heterotrimeric KIF3A/3B/KAP kinesin-2 motor also 
undergoes a salt-dependent shift to a more extended conformation, 
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this possibility, we created additional tagged versions of KIF17 
that contained spacer sequences (18-aa random sequence or a 
20-aa sequence containing a Flag tag) between the mCit tag   
and the KIF17 polypeptide. Interestingly, the addition of spacer 
residues between the FP tag and KIF17 resulted in motors 
(mCit-18aa-KIF17 and mCit-Flag-KIF17) that remained largely 
cytosolic upon addition of AMPPNP (Fig. 1, B and C; and not 
depicted), which suggests that moving the FP further from the 
motor domain allows a return to the autoinhibited state. Our   
interpretation of these results is that KIF17 is regulated by an   
autoinhibition  mechanism  that  prevents AMPPNP-induced   
microtubule binding in the absence of cargo. However, unlike 
other motors tested to date (Cai et al., 2007a; Hammond et al., 
2009), attachment of a bulky epitope tag via short linkers to the 
N or C termini interferes with autoinhibition.
Truncated KIF17 motors retain a  
dimeric state
To identify the domains of KIF17 involved in autoinhibition, 
we  created  truncated  versions  by  removing  successive  seg-
ments from the C-terminus (Fig. 2 C). Analysis of the human 
KIF17 sequence (Fig. 2 B) shows four regions of potential coil 
following the N-terminal motor domain—the neck coil (NC) 
and  coiled-coil  segments  1–3  (CC1-CC3)—followed  by  a   
C-terminal tail domain that can bind to cargo proteins (Setou   
et al., 2000; Takano et al., 2007). When compared with CC pre-
dictions of OSM-3 (Fig. 2 A), the overall domain organization 
appears similar, with the exception of the region between CC1 
and CC2. In OSM-3, this region contains a short hinge segment 
that is required for the folded conformation of the autoinhibited 
motor (Imanishi et al., 2006). In KIF17, this central region con-
tains an 300 residue segment of undefined structure, which 
suggests that the mechanisms of autoinhibition of OSM-3 and 
KIF17 may be different.
Because truncation of the OSM-3 tail domain destabi-
lized the dimeric state of the molecule (Imanishi et al., 2006), 
we analyzed the dimeric state of our truncated KIF17 motors. 
We first used coimmunoprecipitation of Flag/Myc-KIF17 and 
mCit-KIF17 proteins coexpressed in COS cells. As expected, 
mCit-KIF17 coprecipitated with Flag-KIF17 in the presence   
of anti-Flag antibodies but not control (IgG) antibodies (Fig. 2 D,   
left). Likewise, when Myc- and mCit-tagged versions of the 
KIF17 truncations 1–846, 1–738, 1–490, and 1–369 were co-
expressed,  the  mCit-tagged  truncations  coprecipitated  with 
their Myc-tagged counterparts upon addition of anti-Myc but 
not control antibodies (Fig. 2 D, right). These results demon-
strate that FL and truncated versions of KIF17 exist in an oligo-
meric state.
We then used the step-wise photobleaching of mCit to con-
firm the dimerization state of FL and truncated KIF17 motors at 
the single-molecule level. The KIF17 constructs were tagged with 
three tandem copies of mCit (3xmCit) and expressed in COS cells, 
then the lysates were analyzed by total internal reflection fluores-
cence (TIRF) microscopy. For each construct, the fluorescence 
intensity of 100 individual fluorescent molecules was recorded 
over time. The number of bleaching steps was determined for 
each molecule (Cai et al., 2007b; Hammond et al., 2009) and then   
but the activity state of folded and extended motors has not been 
determined (Wedaman et al., 1996).
We set out to uncover the regulatory mechanisms that con-
trol the activity of the kinesin-2 motor KIF17 both in vitro and in 
live cells. We show that, in the absence of cargo, FL KIF17 exists 
in a folded conformation and is inactive for microtubule-based 
motility. We define two molecular mechanisms that contribute to 
autoinhibition of KIF17. First, inhibition of microtubule binding 
is caused by blockage of the motor domain by the C-terminal tail 
domain; and second, inhibition of processive motility is caused 
by a direct interaction between a coiled-coil (CC) segment and 
the motor domain. The latter is a new, as-yet undiscovered mech-
anism for regulation of kinesin motors. In addition, we suggest a 
simple model for KIF17 activation in which cargo binding re-
lieves the autoinhibited state.
Results
KIF17 motors are in an inactive state 
when expressed in mammalian cells
To study the regulation of mammalian KIF17 in its native en-
vironment, tagged versions of human KIF17 were expressed 
in COS cells whose flat morphology is particularly amenable 
to live cell imaging. This approach has been used successfully 
to study kinesin-1 and kinesin-3 motors produced and labeled 
under native conditions, and avoids potential problems associ-
ated with in vitro purification and/or labeling (Cai et al., 2007a).
When expressed in cells, KIF17 motors tagged at the   
N or C termini with small epitope tags (Flag-KIF17 and KIF17- 
Myc) localized diffusely throughout the cytoplasm (Fig. 1 A and 
not depicted). As steady-state expression patterns do not reveal 
whether the motor is actively binding to and/or moving on micro-
tubules, we took advantage of the fact that the nonhydrolyzable 
ATP analogue 5-adenylylimididiphosphate (AMPPNP) locks 
kinesin motors in a microtubule-bound state. Although many 
mechanistic and thermodynamic factors contribute to micro-
tubule binding by kinesin motors, the AMPPNP assay can be used 
to assess the inhibited state of kinesin motors in live cells (Cai   
et al., 2007a; Hammond et al., 2009). The cells were permeabilized 
with the bacterial toxin streptolysin O (SLO), then AMPPNP was 
added, and the cells were fixed and stained with antibodies to the 
epitope tags. Upon addition of AMPPNP, Flag-KIF17 and KIF17-
Myc remained cytosolic and did not become locked in a micro-
tubule-bound state (Fig. 1, A and C; and not depicted). This suggests 
that KIF17 motors exist in an inhibited state when expressed in 
mammalian cells.
To study KIF17 motors in live cells, the motor was tagged 
at the N or C termini with a monomeric version of Citrine (Cit, 
a variant of yellow fluorescent protein [FP]). The monomeric 
citrine (mCit)-KIF17 and KIF17-mCit motors localized dif-
fusely throughout the cytoplasm at steady state but became 
locked in a microtubule-bound state upon addition of AMPPNP 
(Fig. 1, B and C). This indicates that the addition of larger, e.g., 
FP tags, to either end of the molecule interferes with the inhibi-
tory mechanisms that prevent AMPPNP-induced microtubule 
localization. We reasoned that the FP tags may sterically hinder 
motor–tail interactions that contribute to autoinhibition. To test 1015 Autoinhibition of kinesin-2 KIF17 • Hammond et al.
The C-terminal tail domain of  
KIF17 is required for inhibition of 
microtubule binding
We then used the truncated KIF17 constructs to identify regions in-
volved in autoinhibition of microtubule binding. Deletion of the 
KIF17 tail domain resulted in a motor, 1–846, that was diffuse and 
cytosolic at steady state but became trapped in a microtubule-bound 
state upon addition of AMPPNP, regardless of whether 1–846 was 
tagged with mCit (Fig. 3) or Myc tags (Fig. S1). These results indi-
cate that removal of the C-terminal tail region results in a motor that 
is no longer inhibited for AMPPNP-induced microtubule binding.
plotted in a histogram to show the population distribution (Fig. 2 E). 
In control experiments, although we can detect at least 10 bleaching 
steps for 3xmCit-tagged proteins by this method, a maximum of   
six bleaching events were observed for dimeric 3xmCit-tagged   
kinesin-1 motors, whereas a maximum of three bleaching events   
were observed for monomeric 3xmCit-tagged kinesin-3 motors 
(Cai et al., 2007b; Hammond et al., 2009; unpublished data). For 
all FL and truncated KIF17 constructs, no more than six bleaching 
steps were observed (Fig. 2 E). These data indicate that FL and 
truncated KIF17 motors exist in a dimeric state and that the NC 
segment is sufficient for dimerization.
Figure 1.  The kinesin-2 motor KIF17 is inactive for microtubule binding in mammalian cells. (A) Microtubule binding assay in fixed cells. COS cells 
expressing KIF17-Myc were untreated or treated with AMPPNP, then fixed and immunostained with anti-Myc and anti-tubulin antibodies. Bar, 20 µm.   
(B) Microtubule binding assay in live cells. COS cells expressing the indicated mCit-tagged versions of KIF17 were imaged, transiently permeabilized with 
SLO, and treated with AMPPNP. Shown are representative mCit images of the same cells before and after AMPPNP treatment. Bar, 20 µm. (C) Percentage 
of cells in which the indicated tagged versions of KIF17 localized to microtubules (MT) after AMPPNP treatment. At least 150 cells in three independent 
experiments were analyzed for each construct.JCB • VOLUME 189 • NUMBER 6 • 2010   1016
It should also be noted that in the presence of AMPPNP, 
active KIF17 motors still maintain a pool of motors that is local-
ized diffusely throughout the cytoplasm (Figs. 1 and 3; and un-
published data). This is in contrast to active versions of kinesin-1, 
where addition of AMPPNP traps virtually all expressed motors 
on microtubules, effectively clearing the cytoplasm (Cai et al., 
2007a; Hammond et al., 2009). Whether this indicates a weaker 
binding of KIF17 than KHC to microtubules in the presence of 
AMPPNP, or whether these KIF17 motors are still partially in-
hibited for microtubule binding, is presently unclear.
The CC2 segment inhibits the processive 
motility of KIF17
At steady-state, expressed (1–738)-mCit and (1–490)-mCit   
motors showed an accumulation at the periphery of the cell, 
Further truncations of KIF17 that removed the CC3 segment 
([1–795]-mCit], the CC2 segment ([1–738]-mCit), the central re-
gion of unknown structure ([1–490]-mCit), or the CC1 segment 
([1–369])-mCit) resulted in no change in microtubule binding be-
havior. That is, all truncations showed diffuse cytosolic localization 
before addition of AMPPNP and redistributed to a microtubule-
trapped localization upon addition of AMPPNP (Fig. 3). The per-
centage of cells showing microtubule-bound motors in the presence 
of AMPPNP was lower for these truncations than for 1–846 motors 
(Fig. 3), which indicates that the CC3 segment may play a role in 
facilitating microtubule binding, either by interacting directly with 
the microtubule as has been reported for kinesin-1’s kinesin heavy 
chain (KHC) tail domain (Dietrich et al., 2008), or by promoting a 
conformation of the KIF17 motor that facilitates microtubule bind-
ing and/or the retention of AMPPNP in the nucleotide pocket.
Figure 2.  FL and truncated KIF17 constructs exist in a dimeric state. (A, top) Coiled-coil prediction for C. elegans OSM-3 (GenBank/EMBL/DDBJ accession 
no. NP_001023308) using windows of 14 (gray dotted line) or 21 (blue line) amino acids (COILS; http://www.ch.embnet.org/software/COILS_form 
.html). (A, bottom) Schematic of the domain organization of OSM-3. Black oval, motor domain; white ovals, CC segments; black rectangle, tail domain.   
(B) Coiled-coil prediction for human KIF17 (GenBank/EMBL/DDBJ accession no. NP_065867) using windows of 14 (broken line) or 21 (solid line) amino 
acids. In A and B, the y axis gives the probability of CC conformation, and the x axis gives amino acid number. (C) Schematic of the domain organiza-
tion of FL and truncated KIF17 proteins. (D) Coimmunoprecipitation of FL (left) or truncated (right) KIF17 constructs. COS cells were cotransfected with 
plasmids encoding Flag- and mCit-tagged FL KIF17 constructs (left) or Myc- and mCit-tagged truncated KIF17 constructs (right). Lysates were analyzed by 
Western blotting either before (input) or after immunoprecipitation with anti-Flag or control IgG antibodies (for FL; left), or with anti-Myc or control IgG   
antibodies (for truncated constructs; right). (E) Single-molecule photobleaching. Lysates of COS cells expressing the indicated FL or truncated KIF17 con-
structs tagged with 3xmCit were imaged by TIRF microscopy. The number of bleaching steps was counted for individual motors, and the values for the 
population were plotted as a histogram. n = total number of motors counted in at least two independent experiments. The mean number of bleaching steps 
for each construct was 4.4 for FL, 3.8 for 1–846, 3.5 for 1–795, 3.5 for 1–738, 4.3 for 1–490, and 3.8 for 1–369.1017 Autoinhibition of kinesin-2 KIF17 • Hammond et al.
properties, we performed in vitro single-molecule motility   
assays. For this assay, KIF17 motors were tagged with three 
tandem  copies  of  mCit  for  increased  signal  and  decreased 
photoblinking and photobleaching (Cai et al., 2007b). Lysates 
from COS cells expressing KIF17-3xmCit motors were added 
to a flow chamber containing polymerized microtubules and 
assayed by time-lapse imaging on a TIRF microscope. Only 
motility events that lasted at least six frames (300 ms) were 
included in the data analysis. To compare motility properties 
between KIF17 constructs, the amount of expressed protein 
was normalized by Western blotting with an antibody to mCit 
(unpublished data), and each construct was analyzed for the 
same total amount of time.
Few in vitro motility events were detected for FL KIF17-
3xmCit motors (n = 21; Fig. 4, C–E; and Table I), which is 
consistent with their inability to accumulate at the plus ends   
of microtubules in neuronal cells (Fig. 4 A). Analysis of these 
motility events showed that FL KIF17-3xmCit motors moved 
for only short distances (mean run length 0.36 ± 0.04 µm;   
Fig. 4 E and Table I). A limited ability to undergo processive 
motility in vitro was also seen upon removal of the tail domain 
([1–846]-3xmCit) and the CC3 segment ([1–795]-3xmCit; not 
depicted),  which  is  consistent  with  their  in  vivo  behavior   
(Fig. 4 A). However, further truncations that removed the CC2 
segment resulted in a dramatic increase in the number of mo-
tility events observed for (1–738)-3xmCit motors (n = 112; 
Fig. 4, C–E; and Table I) and (1–490)-3xmCit motors (see   
Fig. 8 C and Table III). (1–738)-3xmCit motors moved with a 
mean speed of 0.77 ± 0.02 µm/s (Fig. 4 D and Table I), and 
moved in runs that were as long as 6–7 µm but averaged 1.13 ± 
0.10 µm (Fig. 4 E and Table I). Truncations that remove the 
CC1 segment ([1–369]-3xmCit) resulted in a reduction in the 
number of motility events observed (n = 40) and the mean run 
length (0.45 ± 0.06 µm; Fig. 4 E and Table I), which is consis-
tent with the in vivo analysis (Fig. 4 A), which suggests that 
the CC1 segment may facilitate processive motility. We con-
clude that the CC2 segment plays an important role in auto-
inhibition of KIF17 by preventing processive motility.
presumably at the plus ends of the microtubules, in addition to 
their diffuse cytosolic localization (Fig. 3, arrowheads). This 
suggests that, unlike the FL and other truncated motors, 1–738 
and 1–490 may have the ability to move processively toward the 
plus ends of microtubules. To test this directly, we performed 
two assays that measure the ability of kinesin motors to undergo 
processive motility.
As a first test of the ability of FL and truncated KIF17 
motors to move processively along microtubules, we used 
neuronal cells whose microtubule minus and plus ends are 
spatially segregated to the cell body and neurite tips, respec-
tively. In this assay, active motors accumulate at neurite tips, 
and this localization generally correlates with their proces-
sive motility in vitro (Nakata and Hirokawa, 2003; Lee et al., 
2004; Jacobson et al., 2006; Hammond et al., 2009). When 
expressed in differentiated CAD cells, mCit- and Myc-tagged 
versions of FL KIF17 were primarily localized in the cell   
body and did not concentrate in neurite tips (Fig. 4, A and B;   
and Fig. S2), which suggests that FL KIF17 motors are in-
active for processive motility when expressed in mammalian 
cells. Similar results were obtained for the truncated con-
structs 1–846 and 1–795 (Fig. 4, A and B), even though these 
motors can bind to microtubules in the presence of AMPPNP 
(Fig. 3). These results indicate that microtubule binding and 
processive motility are two separate events that are regulated 
by different segments of the KIF17 protein.
Further truncation to remove the CC2 segment of KIF17 
resulted in a motor, 1–738, that accumulated at the plus ends of   
microtubules in the neurite tips (Fig. 4, A and B). This suggests 
that the CC2 segment is critical for preventing the processive 
movement of KIF17 in mammalian cells. Similar results were 
obtained upon further truncation to remove the central region   
([1–490]-mCit, Fig. 4 A; and [1–490]-Myc, Fig. S2). However, re-
moval of the CC1 segment resulted in a decrease in processive mo-
tility, as (1–369)-mCit motors maintained a pool of motor in the 
cell body in addition to accumulation at neurite tips (Fig. 4 A).
To verify the processive motility of these KIF17 motors 
and  to  obtain  quantitative  information  about  their  motile   
Figure 3.  The C-terminal tail domain is required for inhibition of microtubule binding. Live cell microtubule binding assay. (left) COS cells expressing the 
indicated truncated KIF17 proteins (C-terminal mCit tag) were imaged, transiently permeabilized with SLO, and treated with AMPPNP. Shown are repre-
sentative images of the same cells before and after AMPPNP treatment. Arrowheads indicate active truncated KIF17 motors that have accumulated at the 
plus ends of microtubules. Bar, 20 µm. (right) The percentage of cells in which the indicated KIF17-mCit proteins became locked in a MT-bound state after 
AMPPNP treatment was quantified. At least 150 cells in three independent experiments were analyzed for each construct.JCB • VOLUME 189 • NUMBER 6 • 2010   1018
activity. If so, then KIF17 should undergo conformational changes 
that correlate with its activation, as observed for OSM-3 (Imanishi 
et al., 2006), and the inhibitory CC2 and tail segments should di-
rectly interact with and inhibit the activity of the motor domain.
To test the relationship between KIF17 conformation and 
activity, we performed sucrose gradient sedimentation assays. 
However, we first had to generate mutations in FL KIF17 that 
Mutation of the CC2 segment relieves 
autoinhibition of processive motility
The results presented thus far suggest that two regions of KIF17 are 
involved in autoinhibition of motor activity: the tail domain inter-
feres with microtubule binding (Fig. 3), whereas the CC2 segment 
blocks processive motility (Fig. 4). We hypothesized that KIF17 
exists in a folded state that allows these segments to inhibit motor 
Figure 4.  The CC2 segment is required for inhibition of processive motility. (A) Processive motility in vivo. CAD cells expressing FL or truncated KIF17 
constructs (C-terminal mCit tag) were imaged. Shown are mCit fluorescence (top) and phase contrast (bottom) images of representative cells. Asterisks, 
cell bodies containing inactive KIF17 motors; arrowheads, neurite tips with accumulation of active KIF17 motors. Bar, 20 µm. (B) The percentage of 
cells with the indicated KIF17 construct accumulated at neurite tips. At least ten cells in two independent experiments were counted for each construct.   
(C–E) Processive motility in vitro. Single-molecule motility assays were performed using lysates of COS cells expressing the indicated FL or truncated KIF17 
motors (C-terminal 3xmCit tag). (C) Representative time series showing the motility of individual FL KIF17-3xmCit, (1–738)-3xmCit, and (1–369)-3xmCit 
motors observed by TIRF microscopy. Bars: (vertical red bar) 2 µm; (horizontal black bar) 1 s. (D and E) The measured velocities (D) and run lengths (E) 
were plotted as histograms. n = number of motility events observed for each motor in three independent experiments.
Table I.  Motile properties of truncated KIF17 constructs
KIF17 No. of events observed Speed Run length
µm/s µm
FL KIF17-3xmCit 21 0.71 ± 0.06 0.36 ± 0.04
(1-738)-3xmCit 112 0.77 ± 0.02 1.13 ± 0.01
(1-369)-3xmCit 40 0.79 ± 0.06 0.45 ± 0.061019 Autoinhibition of kinesin-2 KIF17 • Hammond et al.
residues of KIF17 (unpublished data), we mutated Gly754 to 
Glu (G754E) in FL KIF17. This mutation resulted in a dra-
matic accumulation of motors at neurite tips in differentiated 
CAD cells (Fig. 5, C and F), which demonstrates that a single 
point mutation in CC2 is sufficient to relieve autoinhibition of 
FL KIF17.
Because ionic interactions are critical for inhibition of the 
kinesin-1 motor by its tail domain (Stock et al., 1999), we looked 
for charged regions in the tail and CC2 segments of KIF17 that 
could be involved in inhibition of microtubule binding and pro-
cessive motility, respectively. In both the tail domain and the CC2 
segment, a stretch of basic residues was identified and mutated 
result in activation of processive motility. Deletion of the entire 
CC2 segment in a manner that preserves the predicted CC   
architecture of KIF17 (not depicted) resulted in an active motor, 
CC2, that accumulated at neurite tips in differentiated CAD 
cells (Fig. 5, B and F), which confirms that the CC2 segment 
plays a critical role in autoinhibition of KIF17 motility. To gen-
erate more subtle activating mutations, we created a point mu-
tation based on the OSM-3 allele sa125 in which mutation of 
Gly444 to Glu (G444E) results in activation of OSM-3 ATPase 
activity, processive motility in vitro, and chemosensory defects 
in worms (Imanishi et al., 2006). Because Gly444 and surround-
ing residues in OSM-3 align best with Gly754 and adjacent 
Figure 5.  Deletion or mutation of CC2 is sufficient to relieve autoinhibition of processive motility. (A–E, left) Schematics of FL KIF17 (A), constructs in 
which the CC2 domain was deleted (B, CC2), or constructs in which mutations were introduced into the CC2 (C, G754E; and D, 764–772A) or tail   
(E, 1016–1019A) domains. For the mutants, the amino acid sequences of the WT and mutated CC2 (C and D, blue box) or tail (E, black box) segments 
are indicated below the schematic. (A–E, middle) Processive motility in vivo. Differentiated CAD cells expressing the indicated KIF17 constructs (C-terminal 
mCit tag) were imaged. Shown are mCit (fluorescence) and phase contrast images of representative cells. Pink asterisks, cell bodies containing inactive 
KIF17 motors; yellow arrows, neurite tips with accumulation of active KIF17 motors. Bar, 20 µm. (F) The percentage of cells with the indicated KIF17 
construct accumulated at neurite tips. At least 50 cells in two independent experiments were counted for each construct. (A–D, right) Processive motility   
in vitro. Single-molecule motility assays were performed using lysates of COS cells expressing 3xmCit-tagged WT KIF17 (A), G754E mutant (C), or 764-772A 
mutant (D). The measured velocities (red graphs) and run lengths (blue graphs) were plotted as histograms. n values indicate the number of motility events 
observed for each construct in two independent experiments. Bars: (vertical red bar) 2 µm; (horizontal black bar) 1 s.JCB • VOLUME 189 • NUMBER 6 • 2010   1020
was not affected by expression of a Myc-tagged version of 
KIF17’s central region (aa 466–738; Fig. 7, A and B), but 
was abolished upon coexpression of Myc-tagged CC2 + CC3 
or CC2 segments (Fig. 7, A and B). Although expression of 
the Myc-tail domain reduced the accumulation of (1–738)-
mCit motors in neurite tips, the result was not statistically sig-
nificant, perhaps because of nuclear accumulation of the tail 
construct (Fig. 7, A and B).
To  obtain  quantitative  information  about  the  ability  of 
the CC2 and tail segments to inhibit the activity of the KIF17   
motor, we used single-molecule motility assays. Lysates of COS 
cells expressing active (1–490)-3xmCit motors were incubated 
alone or in the presence of recombinant purified GST-tagged CC2 
or tail domains (Fig. 7 C), and the motility of individual motors 
was analyzed by TIRF microscopy. A large number of motility 
events were observed for (1–490)-3xmCit motors alone (Fig. 7 D 
and Table III) and in the presence of GST (Fig. 7 E and Table III).   
When added in trans, the CC2 segment completely blocked   
motor activity, as no motility events were observed for (1–490)-
3xmCit motors in the presence of GST-CC2 (Fig. 7 F and Table III).   
Addition of the GST-tail domain did not completely block motor 
activity but did result in a dramatic reduction in the number of 
motility events observed (Fig. 7 G and Table III).
To test whether inhibition of KIF17 motility is caused by 
direct interactions between the motor domain and the CC2 or 
tail segments, we performed binding assays using recombinant 
GST-tagged motor, CC2, and tail constructs (Fig. 8 A). For these 
experiments, we define the KIF17 motor domain as a dimer of 
to alanines (1016–1019A and 764–772A, respectively; Fig. 5,   
D and E). When expressed in CAD cells, 764-772A motors but 
not 1016-1019A motors showed a dramatic accumulation in neu-
rite tips (Fig. 5, D–F), which indicates that charged residues in 
CC2 may be critical for interaction with the motor domain in the 
autoinhibited state.
To confirm that mutation of residues G754 and 764–772 in 
the CC2 domain results in activation of processive motility, we 
performed in vitro single-molecule motility assays. The motility 
of individual motors in lysates of COS cells expressing 3xmCit-
tagged versions of FL KIF17, G754E, or 764–772A motors was 
determined by time-lapse TIRF microscopy. Again, few motility 
events were observed for FL KIF17 (n = 8; Fig. 5 A and Table II). 
However, mutation of either G754E or 764–772A resulted in a 
dramatic increase in the number of motility events observed as 
well as the overall speed and processivity of the motor (Fig. 5, 
C and D; and Table II). Notably, mutation of the basic residues 
764–772 resulted in a larger increase in KIF17 activation than 
mutation of the single glycine residue. Collectively, these results 
demonstrate that the CC2 segment plays a critical role in auto-
inhibition of processive motility and that the ionic interactions 
between CC2 and the KIF17 motor domain may be critical for 
this regulation.
Release of inhibition correlates with a shift 
to an extended conformation
We then used sucrose gradient sedimentation analysis to test 
the relationship between KIF17 activity and conformation. 
Lysates of COS cells expressing Flag-tagged versions of in-
active (FL) and active (G754E and 764–772A) KIF17 motors 
were loaded on the top of linear sucrose gradients and separated 
by sedimentation. The majority of FL KIF17 motor was found 
in fractions 6 and 7 (Fig. 6). Mutation of G754E or 764–772A 
resulted in a slower migration in the sucrose gradients (Fig. 6), 
which is consistent with the possibility that the active motors 
are in an extended conformation. A similar shift in sedimen-
tation behavior was observed for the activated OSM-3(G444E) 
motor (Imanishi et al., 2006). The change in sedimentation is 
consistent with the hypothesis that KIF17 undergoes a conforma-
tional transition between an inactive folded state and an active 
extended state.
The CC2 and tail segments inhibit KIF17 
motility via direct interactions with the 
motor domain
We tested whether the CC2 and tail constructs could act in 
trans to inhibit the processive motility of active KIF17 mo-
tors. In differentiated CAD cells, the ability of active (1–738)-
mCit motors to accumulate in neurite tips (Fig. 7, A and B) 
Table II.  Motile properties of mutant FL KIF17 constructs
KIF17 No. of events observed Speed Run length
µm/s µm
FL KIF17-3xmCit 8 0.48 ± 0.07 0.64 ± 0.11
FL(G754E)-3xmCit 31 0.64 ± 0.04 0.58 ± 0.06
FL(764-772A)-3xmCit 101 0.72 ± 0.02 1.07 ± 0.05
Figure 6.  Mutations in CC2 that relieve autoinhibition convert the motor 
to an extended conformation. Lysates of COS cells expressing Flag-tagged 
FL KIF17, or the G754E or 764-772A mutants were subjected to sucrose 
gradient sedimentation. Fractions were removed from the top (lane 1), run 
on SDS-PAGE, and immunoblotted with an antibody to the Flag tag. T, total 
lysate. The sedimentation of the size standards catalase (C; 11.3 S) and 
malate dehydrogenase (M; 4.3 S) is indicated on the bottom.1021 Autoinhibition of kinesin-2 KIF17 • Hammond et al.
proteins. GST alone was used as a control and did not bind to 
the motor (Fig. 8 C, lane 1). The CC2 segment was able to inter-
act directly with the motor as GST-CC2 protein bound to the 
column (Fig. 8 C, lane 2), but this interaction was dramatically 
reduced by mutation of the basic residues 764–772 (Fig. 8 C, 
lane 3). In contrast, both WT and mutant 1016-1019A forms 
of the tail domain bound to the motor (Fig. 8 C, lanes 4 and 5). 
These results indicate that both CC2 and tail segments inter-
act directly with the KIF17 motor domain and that residues 
764–772 are critical for the interaction of CC2 with the motor. 
We conclude that autoinhibition of KIF17 results from intra-
molecular interactions between the KIF17 motor domain and 
the CC2 and tail segments in the folded inactive state.
heads, including the NC and CC1 segments. We generated both 
wild-type (WT) and mutant (764–772A and 1016–1019A) ver-
sions of the CC2 and tail domains, and in both cases, mutation of 
the basic residues resulted in a faster mobility in SDS-PAGE gels 
(Fig. 8 B). The WT and mutant GST-tail constructs were highly 
susceptible to proteolysis (Fig. 8 B).
Direct binding assays were performed by loading GST-
KIF17(1–490)-Myc motors in a column via anti-Myc anti-
bodies. Purified GST-tagged WT and mutant (764–772A) versions 
of the CC2 segment, and WT and mutant (1016–1019A) ver-
sions of the tail domain were allowed to bind to the column. 
After extensive washing, the bound fraction was analyzed   
by Western blotting with an anti-GST antibody to detect all 
Figure 7.  The CC2 and tail domains inhibit KIF17 motility in trans. (A) Processive motility in vivo. Differentiated CAD cells expressing (1–738)-mCit motor 
alone (NT, nontransfected control) or together with the indicated Myc-tagged constructs were fixed and stained with an antibody to the Myc tag. Asterisks, 
cell bodies containing inactive KIF17 motors; arrowheads, neurite tips with accumulation of active KIF17 motors. (B) Quantification of the percentage of 
cells with (1–738)-mCit tip accumulation from three independent experiments. *, P < 0.05. (C–F) Processive motility in vitro. Single-molecule motility assays 
were performed for (1–490)-3xmCit motors alone (D) or in the presence of recombinant purified GST (E), GST-CC2 (F), or GST-tail (G) proteins. The speed 
(red graphs) and run lengths (blue graphs) of the observed events were plotted as histograms. n = number of motility events observed in two independent 
experiments. Each frame is 50 ms. Bars: (A) 20 µm; (D, E, and G) 2 µm.JCB • VOLUME 189 • NUMBER 6 • 2010   1022
conformation. In this way, the mechanism of KIF17 regulation   
is similar to that of kinesin-1 (Verhey and Hammond, 2009).
The folded conformation enables two regions of KIF17—
the CC2 segment and the tail domain—to interact directly with 
and inhibit the enzymatic activity of dimeric KIF17 motors. In the 
case of the inhibitory tail domain, we have not been able to identify 
residues that contribute to the direct interaction with the motor   
domain and/or autoinhibition of motor activity. In the case of the 
inhibitory CC2 segment, we identified two mutations, G754E and 
762-772A, that result in activation of processive motility and a cor-
responding conversion to a more extended conformation. We pro-
pose that G754 contributes to a hinge region that enables the folded 
conformation, similar to the role of G444 in OSM-3 (Imanishi et al., 
2006). We propose that residues 764–772 are involved in ionic   
interactions with the motor domain in the folded conformation,   
although we cannot exclude the possibility that residues 764–772 
are critical for an overall structural conformation of the CC2 seg-
ment required for interaction with the motor domain.
The fact that ionic interactions play a critical role in medi-
ating the interaction of inhibitory segments with the KIF17 motor 
domain in the autoinhibited state is similar to the regulatory 
Discussion
In the absence of cargo, kinesin activity must be tightly con-
trolled to prevent futile ATP hydrolysis and congestion of 
microtubule tracks. Recent work has demonstrated that auto-
inhibition may be a general mechanism for the regulation of kine-
sin motors that drive intracellular trafficking events (Verhey and   
Hammond, 2009). We provide the first demonstration that mam-
malian kinesin-2 motors are regulated by autoinhibition and 
determine two intramolecular mechanisms that contribute to   
regulation of KIF17 in vitro and in live cells.
Autoinhibition is caused by a folded 
conformation that enables direct 
interactions between KIF17 motor  
and nonmotor regions
We demonstrate that FL KIF17 is in an inactive state when ex-
pressed under native conditions, as the motor can neither be 
locked  on  microtubules  by AMPPNP  nor  undergo  processive   
motility to the plus ends of microtubules. We also show that   
activation of KIF17 correlates with a shift to a more extended 
Table III.  Effects of the CC2 and tail domains on the motility of KIF17 motors
KIF17 No. of events observed Speed Run length
µm/s µm
(1-490)-3xmCit 122 0.90 ± 0.03 0.87 ± 0.04
(1-490)-3xmCit + GST 125 0.93 ± 0.02 1.13 ± 0.05
(1-490)-3xmCit + GST-CC2 0 NA NA
(1-490)-3xmCit + GST-tail 23 0.80 ± 0.04 0.76 ± 0.08
NA, not applicable.
Figure 8.  The CC2 and tail domains interact directly with the KIF17 motor. (A) Schematic of GST-tagged constructs. (B) Coomassie-stained gel showing 
recombinant, purified GST-(1–490)-Myc motor, WT and mutant GST-CC2, and WT and mutant GST-tail proteins. (C) GST-(1–490)-Myc protein was bound 
to an anti-Myc column, then GST-tagged versions of WT or mutant (764–772A) CC2 domains as well as WT or mutant (1016–1019A) tail domains were 
added to the column. GST was used as a control. The column-bound proteins were identified by immunoblotting with an anti-GST antibody. Boxed regions 
indicate proteins of interest. The numbers to the left of the gel blots indicate protein size markers in kD.1023 Autoinhibition of kinesin-2 KIF17 • Hammond et al.
Cargo-mediated activation of KIF17
Autoinhibition of motor activity leads to a simple model where 
cargo binding relieves the inhibitory mechanism, enabling sub-
sequent microtubule-based motility. In this work, we demonstrate 
that KIF17 can be activated for microtubule binding but not proces-
sive activity by attachment of an FP to the N or C termini of KIF17 
via short linkers (i.e., mCit-KIF17 and KIF17-mCit). Similar FP 
fusions do not result in activation of kinesin-1 or kinesin-3 motors 
(Cai et al., 2007a; Hammond et al., 2009). These results suggest 
that the presence of the FP interferes with inhibitory interactions 
between motor and tail regions of KIF17 in the folded state.
For both kinesin-1 and the kinesin-2 motor OSM-3, release 
of autoinhibition by cargo binding can be mimicked in vitro by   
attachment of beads to the tail of the motor (Coy et al., 1999;   
Imanishi et al., 2006). How motors are activated in vivo is largely 
unknown. Recent work has shown that activation of kinesin-1 in 
cells requires binding partners of both inhibitory segments (tail of 
the KHC and KLC subunits) to relieve autoinhibition (Blasius   
et al., 2007). We propose that KIF17 is activated in vivo by cargo 
proteins, e.g., intraflagellar transport components that enable tar-
geting to and processive motility in cilia. As two mechanisms con-
tribute to autoinhibition of KIF17, it seems likely that at least two 
binding partners are needed for full activation of motor activity. 
Further elucidation of the mechanisms of KIF17 activation will 
require the identification of binding partners of the inhibitory 
CC2 and tail segments.
Materials and methods
Plasmids and antibodies
Full-length or truncated human KIF17 constructs were generated by PCR 
amplification from HsKIF17 cDNA (GenBank/EMBL/DDBJ accession no. 
NP_065867). KIF17 internal deletions and mutations were made by over-
lapping PCR or QuikChange (Agilent Technologies). PCR products were 
cloned into the mCit-N1 or C1 vectors (modified from Takara Bio Inc.’s 
EYFP-N1/C1 vectors), the 3xmCit-N1 vector (Cai et al., 2007b), pcDNA3-
Flag/Myc vectors, or pGEX-5X (GE Healthcare) using convenient restric-
tion sites. Linker sequences for KIF17 constructs with N-terminal epitope 
tags were: SGAG for mCit-KIF17, AGGILSGGAVSGGASGAG for mCit-
18aa-KIF17, SGLRSMDYKDDDDKSHGGGA for mCit-Flag-KIF17, and GGGA 
for Flag-KIG17. Linker sequences for KIF17 constructs with C-terminal epitope 
tags were: TV for KIF17-Myc and TVPRARDPPVAT for KIF17-mCit. All plas-
mids were verified by DNA sequencing. KHC-mCit and mCFP-KLC have 
been  described  previously  (Cai  et  al.,  2007a).  The  following  anti-
bodies were used: Myc (clone 9E10; Sigma-Aldrich), Flag (clone M2; Sigma-
Aldrich),  GFP  (used  to  recognize  mCit;  Invitrogen),  GST  (Santa  Cruz 
Biotechnology, Inc.), and anti–-tubulin (clone E7; Developmental Studies 
Hybridoma Bank).
Cell culture and immunofluorescence
COS and CAD cells were cultured, transfected, and processed for immuno-
fluorescence  as  described  previously  (Blasius  et  al.,  2007;  Cai  et  al., 
2007a). COS cells were grown in DME with 10% Fetal Clone III (Thermo 
Fisher Scientific), and CAD cells were grown in 1:1 F12:DME (Lonza) with 
10% FBS (HyClone) at 37°C and 5% CO2. The cells were transfected with 
Trans-It LT1 (Mirus Bio LLC) according to the manufacturer’s instructions. Cells 
were fixed with 3.7% paraformaldehyde, permeabilized with 0.2% Triton   
X-100, and blocked with 0.2% fish skin gelatin, all in PBS. After staining, the 
coverslips were mounted in ProLong Gold (Invitrogen). Images were col-
lected on a microscope (TE2000; Nikon) using Plan-Fluor 40×, NA 0.75 or 
Plan-Apochromat 60× NA 1.4 objectives, a camera (CS ES2; Photometrics), 
and MetaMorph software (MDS Analytical Technologies).
Coimmunoprecipitation and sucrose gradient sedimentation
18–24 h after transfection, COS cells were resuspended in lysis buffer 1 
(25 mM Hepes/KOH, 115 mM potassium acetate, 5 mM sodium acetate, 
mechanism of kinesin-1 (Verhey and Hammond, 2009). These 
intramolecular interactions appear to be quite weak in trans, as 
direct interactions between motor and nonmotor segments could 
not be detected in conventional pull-down experiments (unpub-
lished data) but only when present at high concentrations on a 
column. Within the FL molecule, the folded conformation en-
ables weak interactions to become biochemically strong and 
mechanistically important.
Two molecular mechanisms contribute to 
KIF17 autoinhibition
We define two molecular mechanisms (Fig. 8 D) that contribute 
to autoinhibition of folded KIF17 motors both in vitro and in live 
cells. In the first mechanism, the KIF17 tail domain interacts di-
rectly with the dimeric motor and interferes with microtubule 
binding. Whether the tail domain blocks the initial interaction of 
the KIF17 motor with the microtubule or accelerates the release 
of ADP-bound KIF17 requires further mechanistic analysis. In 
the second mechanism, the CC2 segment interacts directly with 
the dimeric motor and blocks processive motility. This is the first 
direct demonstration that kinesin motors can be regulated by an 
autoinhibitory mechanism that directly interferes with the ability 
of the motor to undergo processive movement.
Dual regulatory mechanisms have recently been shown 
to contribute to the autoinhibitory mechanisms of mammalian   
kinesin-1 and kinesin-3 motors (Cai et al., 2007a; Hammond   
et al., 2009). In the case of kinesin-1, the KHC tail domain inter-
acts with the motor domain and interferes with the initial micro-
tubule interaction, whereas the kinesin light chain (KLC) subunit 
blocks processive motility (Coy et al., 1999; Hackney and Stock, 
2000; Cai et al., 2007a). The fact that the exact sequences and 
secondary structural elements required for autoinhibition differ 
between kinesin motors suggests that the evolutionary develop-
ment of the kinesin superfamily involved the adoption of unique 
cargo-binding regions together with mechanisms for regulation 
of the common kinesin catalytic domain.
Role of the NC and subsequent  
hinge segments in dimerization and 
processive motility
We demonstrate that human KIF17 exists in a dimeric state, 
which  is  consistent  with  hydrodynamic  analysis  of  KIF17/
OSM-3 motors from other species (Signor et al., 1999; Setou   
et al., 2000), and that the NC segment is sufficient for dimer-
ization of truncated KIF17(1–369) motors. Yet surprisingly, 
(1–369)-mCit motors showed reduced processivity in vivo and   
in vitro as compared with (1–490)-mCit motors. We propose 
that the hinge segment between the NC and CC1 segments fa-
cilitates processive motility, perhaps by stabilizing the coiled 
structure of the NC and/or by facilitating the motor–microtubule 
interaction. Similarly positioned hinge segments in kinesin-1 
and kinesin-3 motors have been noted to positively affect pro-
cessive motility via stabilizing effects on dimer formation and the 
motor–microtubule interaction (Thormählen et al., 1998; Thorn 
et al., 2000; Kallipolitou et al., 2001). Thus, it seems likely that 
processive motility of dimeric kinesin motors is influenced by 
sequences in the motor–proximal hinge segment.JCB • VOLUME 189 • NUMBER 6 • 2010   1024
Online supplemental material
Fig. S1 shows that Myc-tagged 1–846 behaves similarly to mCit-tagged 1–846 
in its localization to microtubules in the presence of AMPPNP. Fig. S2 shows 
that Myc-tagged FL and truncated motors behave similarly to mCit-tagged 
motors in their localization to neurite tips. Online supplemental material is 
available at http://www.jcb.org/cgi/content/full/jcb.201001057/DC1.
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5 mM MgCl2, 0.5 mM EGTA, 1% Triton X-100, and protease inhibitors;   
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lyzed by SDS-PAGE and Western blotting. Catalase (11.3 S, 256 kD; 
EMD) and malate dehydrogenase (4.3 S, 66 kD; Sigma-Aldrich) were 
used as standards.
In vivo microtubule binding assay
COS cells were plated onto glass-bottomed dishes (MatTek Corporation) 
and transfected with plasmids encoding the proteins of interest. 24 h later, 
cells were viewed on an inverted microscope (TE2000; Nikon). Cells were 
treated with 0.1 µg/ml SLO in permeabilization buffer (PB; 25 mM Hepes/
KOH, 115 mM potassium acetate, 5 mM sodium acetate, 5 mM MgCl2, 
0.5 mM EGTA, and 10 mg/ml BSA; pH 7.4) for 1 min. After washing three 
times with PB, cells were incubated with PB containing 2 mM AMPPNP. 
Cells were monitored every minute for an additional 15 min. Alternatively, 
cells were treated with SLO and AMPPNP in the presence of taxol for   
10 min. Then, cells were fixed and stained for immunofluorescence using 
Flag, HA, or Myc antibodies.
In vitro single molecule motility and photobleaching assays
Motility assays were performed in flow chambers as described previously 
(Cai et al., 2007b), except that P25 buffer (25 mM Pipes/KOH, 1 mM 
EGTA, and 2 mM MgCl2, pH 6.8) was used in place of P12. In brief, motor 
proteins were prepared by lysing transfected COS cells in lysis buffer 2 
with 1 mM ATP. 5–10 µl of cell lysate was added to flow chambers contain-
ing taxol-stabilized microtubules and 40–45 µl of oxygen scavenger buffer 
(1 mM DTT, 1 mM MgCl2, 2 mM ATP, 10 mM glucose, 0.1 mg/ml glucose 
oxidase, 0.08 mg/ml catalase, 10 mg/ml BSA, and 10 µM taxol in P25). 
Lysates were incubated with ATP for motility assays or with AMPPNP for 
photobleaching analysis. The 488-nm line of a tunable, single-mode, fiber-
coupled argon ion laser (CVI Melles Griot) was used for excitation. An   
objective-type TIRF microscope and a back-illuminated EM charge-coupled 
device camera (Cascade 512B; Roper Industries) were used to capture   
images every 100 ms. Measurements for each construct come from at least 
two independent protein preparations. Velocity and track length measure-
ments  were  obtained  using  homemade  plug-ins  written  for  ImageJ   
(National Institutes of Health) and include motile events lasting at least 0.3 s. 
All data are presented as mean ± standard error.
GST protein purification
The expression of GST fusion proteins was induced in Rosetta 2 Escherichia 
coli by addition of 1 mM IPTG for 2–4 h. Cell pellets were resuspended 
in 50 mM Tris, pH 7.5, 0.5 mM EDTA, and 0.3 M NaCl plus 1 mg/ml   
lysozyme,  4  mM  DTT,  proteosome  inhibitors,  and  0.2%  NP-40,  then 
stored overnight at 80°C. Samples were thawed on ice, NaCl was 
added to 750 mM, and MgCl2 was added to 6 mM, then the samples 
were incubated with 0.1 mg Dnase1 for 2 h at 4°C. Samples were then 
sonicated at 60% amplitude and centrifuged at 15,000 g for 20 min at 
4°C. Soluble protein was incubated with glutathione sepharose beads 
(GE Healthcare) for 2 h at 4°C. The beads were washed with 1% Triton 
X-100 in PBS and again with PBS alone. Protein was eluted with 10 mM of 
reduced L-glutathione (Sigma-Aldrich), 50 mM Tris, pH 8.0, and 0.2 mM 
EDTA. Protein-containing fractions were pooled and dialyzed overnight 
against 10 mM Tris, pH 7.4, 100 mM NaCl, 1 mM EDTA, 5% glycerol, and 
1 mM DTT. For GST-KIF17(1–490)-Myc motors, 100 µM ATP was present 
throughout purification.
In vitro binding assay
Purified  GST-KIF17(1–490)-Myc  was  incubated  with  anti-Myc  agarose 
beads (Sigma-Aldrich) for 20 min at 4°C, loaded into columns, and washed 
with P12/ATP (12 mM Pipes/KOH, pH 6.8, 1 mM EGTA, 2 mM MgOAc, 
and 100 µM ATP). Purified GST, GST-CC2, or GST-tail proteins in P12/ATP 
buffer were incubated with the motor-bound beads for 20 min at 4°C. Un-
bound protein was removed by extensive washing with P12/ATP buffer. The 
beads were then removed from the column, resuspended in sample buffer, 
and analyzed by SDS-PAGE and Western blotting.1025 Autoinhibition of kinesin-2 KIF17 • Hammond et al.
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